Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML
Clinical trial NCT06741722 · RECRUITING
Trial details
- NCT number
- NCT06741722
- Sponsor
- Beijing 302 Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-10-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.